Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ONO 9902

Known as: ONO-9902 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Background and Aim of work: The aim of the current study is to evaluate the effects of acute and chronic inhibition of NEP, by… Expand
  • table 1
  • table 2
2004
2004
Vasopeptidase inhibitors possess dual inhibitory actions on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2001
2001
OBJECTIVE Increased secretion of atrial and brain natriuretic peptide (ANP and BNP) from hearts is known to exhibit favorable… Expand
  • table 1
  • table 2
  • figure 3
  • table 3
  • table 4
1998
1998
A series of (4S)-4-[(2S)-benzyl-3-mercaptopropionylamino]-4-(N-phenylcarbamoyl )-butyric acids has been identified as potent… Expand
1996
1996
PurposeThe present study was designed to examine the antinociceptive effects of orally administered ONO-9902, an enkephalinase… Expand
  • figure 1
  • figure 2
1990
1990
-INVESTIGATION: This study investigated on the antinociceptive effects of a novel AIM orally active enkephalinase inhibitor, ONO… Expand
1990
1990
-INVESTIGATION: This study investigated on the antinociceptive effects of a novel AIM orally active enkephalinase inhibitor, ONO… Expand